Location History:
- Los Angeles, CA (US) (2019)
- Encino, CA (US) (2017 - 2020)
Company Filing History:
Years Active: 2017-2020
Title: Min Liang: Innovator in RNAi and Gene Therapy Technologies
Introduction
Min Liang, an accomplished inventor based in Encino, California, has made significant contributions to the fields of RNA interference (RNAi) and gene therapy. With three patents to his name, his work centers around innovative delivery platforms designed to enhance the efficacy and safety of therapeutic applications.
Latest Patents
Among his latest inventions is an RNAi molecule delivery platform that utilizes single-siRNA and shRNA nanocapsules. This groundbreaking technology features highly robust and effective delivery methods, which result in low toxicity and extended intracellular half-life for practical therapeutic uses. Furthermore, he has developed a viral vector nanocapsule aimed at targeting gene therapy more effectively. This invention introduces novel methods and materials that allow for the generation of viral vectors with altered tissue and cell targeting capabilities. By employing a thin polymer shell that is synthesized and coupled to the viral envelope, these vectors can achieve improved stability and enhanced infection efficiency in both dividing and non-dividing cells.
Career Highlights
Min Liang is affiliated with the University of California, where he engages in research that bridges the gap between advanced scientific concepts and real-world medical applications. His work has helped pave the way for more effective and safer gene therapies.
Collaborations
Min Liang collaborates with esteemed colleagues Yunfeng Lu and Ming Yan, with whom he shares a commitment to advancing the understanding and applications of gene therapy technologies. These collaborations have proved fruitful, enhancing the quality and impact of their research initiatives.
Conclusion
Min Liang stands out as a vital figure in the world of biotechnology, leveraging his innovative spirit to advance the field of RNAi and gene therapy. His dedication to developing effective delivery systems holds promising implications for the future of therapeutic approaches.